Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor

Publication date: Available online 10 June 2021Source: Computational and Structural Biotechnology JournalAuthor(s): Sarah Naomi Bolz, Sebastian Salentin, Gary Jennings, V. Joachim Haupt, Jared Sterneckert, Michael Schroeder

Source: Computational and Structural Biotechnology Journal - June 11, 2021 Category: Biotechnology Source Type: research